Tramadol Hydrochloride
NDC 21695-699
Product Information
Tramadol Hydrochloride is a ANDA-approved product labeled by Rebel Distributors Corp.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white product. This product entry covers the primary NDC 21695-699 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
PAR821
Code Structure Chart
Product Details
What is NDC 21695-699?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TRAMADOL HYDROCHLORIDE (UNII: 9N7R477WCK)
- TRAMADOL (UNII: 39J1LGJ30J) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- COLLOIDAL SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- DIBUTYL SEBACATE (UNII: 4W5IH7FLNY)
- ETHYLCELLULOSE (UNII: 7Z8S9VYZ4B)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYVINYL ALCOHOL (UNII: 532B59J990)
- POVIDONE K90 (UNII: RDH86HJV5Z)
- SHELLAC (UNII: 46N107B71O)
- FERRIC OXIDE BLACK (UNII: XM0M87F357)
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- AMMONIA (UNII: 5138Q19F1X)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 833709 - traMADol HCl 100 MG 24HR Extended Release Oral Tablet
- RxCUI: 833709 - 24 HR tramadol hydrochloride 100 MG Extended Release Oral Tablet
- RxCUI: 833709 - tramadol hydrochloride 100 MG 24 HR Extended Release Oral Tablet
- RxCUI: 833711 - traMADol HCl 200 MG 24HR Extended Release Oral Tablet
- RxCUI: 833711 - 24 HR tramadol hydrochloride 200 MG Extended Release Oral Tablet
* Please review the full disclaimer at the bottom of this page.